ISB 1442

DB18475InvestigationalProtein Based Therapies

ISB 1442 is a bispecific, biparatopic antibody targeting CD38 and CD47.

Mechanism: Pharmacologically active on ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 and Leukocyte surface antigen CD47
Curator reviewed
Code names: ISB-1442

Resolves to

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with ISB 1442, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.